US 9334244
Compounds useful as inhibitors of ATR kinase
granted A61KA61K31/4965A61K31/497
Quick answer
US patent 9334244 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4965, A61K31/497, A61K33/243, A61P